Amarin Corp Plc\Uk financial data

Symbol
AMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2, Ireland
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
AMARIN PHARMACEUTICALS PLC (to 7/13/2000), ETHICAL HOLDINGS PLC (to 1/28/1998)
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278 % +15.2%
Quick Ratio 97.5 % +23.7%
Debt-to-equity 49.6 % -9.08%
Return On Equity -9.48 % +38.6%
Return On Assets -6.34 % +36.6%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 411M shares +0.85%
Entity Public Float 485M USD -32.8%
Common Stock, Value, Issued 305M USD +1.15%
Weighted Average Number of Shares Outstanding, Basic 410M shares +0.98%
Weighted Average Number of Shares Outstanding, Diluted 410M shares +0.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 277M USD -23%
Research and Development Expense 22.1M USD -15%
Operating Income (Loss) -63.8M USD +32.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.8M USD +46.8%
Income Tax Expense (Benefit) 4.78M USD +538%
Net Income (Loss) Attributable to Parent -52.6M USD +42%
Earnings Per Share, Basic -0.13 USD/shares +40.9%
Earnings Per Share, Diluted -0.13 USD/shares +40.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 214M USD +11.8%
Accounts Receivable, after Allowance for Credit Loss, Current 116M USD -13.1%
Inventory, Net 255M USD +13%
Assets, Current 688M USD +0.6%
Property, Plant and Equipment, Net 81K USD -56.7%
Operating Lease, Right-of-Use Asset 7.88M USD -14.3%
Other Assets, Noncurrent 1.32M USD -19.2%
Assets 790M USD -8.16%
Accounts Payable, Current 67.6M USD +15%
Employee-related Liabilities, Current 18.9M USD -6.7%
Contract with Customer, Liability, Current 2.34M USD +6.46%
Liabilities, Current 224M USD -8.13%
Contract with Customer, Liability, Noncurrent 2.11M USD -83.4%
Operating Lease, Liability, Noncurrent 8.39M USD -14.8%
Other Liabilities, Noncurrent 9.2M USD +6.84%
Liabilities 244M USD -11.4%
Retained Earnings (Accumulated Deficit) -1.6B USD -3.41%
Stockholders' Equity Attributable to Parent 546M USD -6.65%
Liabilities and Equity 790M USD -8.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -79.8%
Net Cash Provided by (Used in) Financing Activities -1.43M USD -492%
Net Cash Provided by (Used in) Investing Activities 28.7M USD
Common Stock, Shares, Issued 421M shares +1.25%
Common Stock, Par or Stated Value Per Share 0.5 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Deferred Tax Assets, Valuation Allowance 172M USD +3.88%
Deferred Tax Assets, Gross 176M USD +3.52%
Operating Lease, Liability 10.1M USD -13.7%
Depreciation 200K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid 13.9M USD -16.4%
Property, Plant and Equipment, Gross 1.49M USD -55.4%
Operating Lease, Liability, Current 1.73M USD -4.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.17M USD +1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.31M USD -18.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.75M USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.96M USD -8.06%
Deferred Tax Assets, Operating Loss Carryforwards 154M USD +12.6%
Deferred Federal Income Tax Expense (Benefit) 9.93M USD
Current Income Tax Expense (Benefit) 5.44M USD +172%
Unrecognized Tax Benefits 18.7M USD -0.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.98M USD +0.82%
Additional Paid in Capital 1.9B USD +0.65%
Current State and Local Tax Expense (Benefit) 243K USD -57.6%
Current Federal Tax Expense (Benefit) 1.6M USD +184%
Amortization of Intangible Assets 729K USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 4.52M USD -8.54%
Deferred State and Local Income Tax Expense (Benefit) -934K USD -429%
Interest Expense 15K USD -88.4%